Array-based comparative genomic hybridization for the detection of DNA sequence copy number changes in Barrett's adenocarcinoma

Journal of Pathology

Volumn 203, Issue 3, 2004, Pages 780-788

  Albrecht, Bettina ^a   Hausmann, Michael ^a   Zitzelsberger, Horst ^b   Stein, Hubert ^c   Siewert, Jörg Rüdiger ^c   Hopt, Ulrich ^a   Langer, Rupert ^c   Höfler, Heinz ^c   Werner, Martin ^a   Walch, Axel ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Array CGH; Barret's adenocarcinoma; DNA sequence copy number changes

Indexed keywords

BIOLOGICAL MARKER; FORMALDEHYDE; PARAFFIN;

ARTICLE; CARCINOGENESIS; CARDIA; CHROMOSOME; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; DNA SEQUENCE; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE IDENTIFICATION; GENOMICS; HUMAN; HUMAN TISSUE; ONCOGENE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STOMACH MUCOSA; TISSUE SECTION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; BARRETT ESOPHAGUS; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECANCEROUS CONDITIONS;

EID: 3242665312     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1576     Document Type: Article

References (21)

1. Wild CP, Hardie LJ. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nature Rev Cancer 2003; 3: 676 684.
2. Riegman PH, Burgart LJ, Wang KK, et al. Allelic imbalance of 7q32.3 q36.1 during tumorigenesis in Barrett's esophagus. Cancer Res 2002; 62: 1531 1533.
3. Walch AK, Zitzelsberger HF, Bruch J, et al. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia dysplasia carcinoma sequence. Am J Pathol 2000; 156: 555 566.
4. Bentz M, Plesch A, Stilgenbauer S, Dohner H, Lichter P. Minimal sizes of deletions detected by comparative genomic hybridization. Genes Chromosomes Cancer 1998; 21: 172 175.
5. Kirchhoff M, Gerdes T, Maahr J, et al. Deletions below 10 megabase pairs are detected in comparative genomic hybridization by standard reference intervals. Genes Chromosomes Cancer 1999; 25: 410 413.
6. Albertson DG, Pinkel D. Genomic microarrays in human genetic disease and cancer. Hum Mol Genet 2003; 12: R145 R152.
7. Schraml P, Schwerdtfeger G, Burkhalter F, et al. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5 q14 as a critical oncogene target in ovarian carcinoma. Am J Pathol 2003; 163: 985 992.
8. Weiss MM, Snijders AM, Kuipers EJ, et al. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization. J Pathol 2003; 200: 320 326.
9. Veltman JA, Fridlyand J, Pejavar S, et al. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 2003; 63: 2872 2880.
10. Beheshti B, Braude I, Marrano P, Thorner P, Zielenska M, Squire JA. Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization. Neoplasia 2003; 5: 53 62.
11. Hyman E, Kauraniemi P. Hautaniemi S, et al. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 2002; 62: 6240 6245.
12. Redon R, Hussenet T, Bour G, et al. Amplicon mapping and transcriptional analysis pinpoint cyclin L as a candidate oncogene in head and neck cancer. Cancer Res 2002; 62: 6211 6217.
13. Hui AB, Lo KW, Teo PM, To KF, Huang DP. Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization. Int J Oncol 2002; 20: 467 473.
14. Hui AB, Lo KW, Yin XL, Poon WS, Ng HK. Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. Lab Invest 2001; 81: 717 723.
15. Wessendorf S, Fritz B, Wrobel G, et al. Automated screening for genomic imbalances using matrix-based comparative genomic hybridization. Lab Invest 2002; 82: 47 60.
16. Walch A, Specht K, Bink K, et al. Her-2/neu gene amplification, elevated mRNA expression, and protein overexpression in the metaplasia dysplasia adenocarcinoma sequence of Barrett's esophagus. Lab Invest 2001; 81: 791 801.
17. Nicholls RD, Saitoh S, Horsthemke B. Imprinting in Prader-Willi and Angelman syndromes. TIG 1998; 14: 194 200.
18. Iravani S, Zhang HQ, Yuan ZQ, et al. Modification of insulin-like growth factor 1 receptor, c-Src, and Bc1-XL protein expression during the progression of Barrett's neoplasia. Hum Pathol 2003; 34: 975 982.
19. Sarbia M, Arjumand J, Wolter M, Reifenberger G. Heep H, Gabbert HE. Frequent c-myc amplification in high-grade dysplasia and adenocarcinoma in Barrett esophagus. Am J Clin Pathol 2001; 115: 835 840.
20. Michael D, Beer DG, Wilke CW, Miller DE. Glover TW. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas. Oncogene 1997; 15: 1653 1659.
21. Barrett MT, Sanchez CA, Galipeau PC, Neshat K, Emond M, Reid BJ. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene 1996; 13: 1867 1873.